.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
US Army
Covington
Colorcon
Baxter
Moodys
UBS
US Department of Justice
Johnson and Johnson

Generated: November 24, 2017

DrugPatentWatch Database Preview

OMNIPAQUE 140 Drug Profile

« Back to Dashboard

What is the patent landscape for Omnipaque 140, and when can generic versions of Omnipaque 140 launch?

Omnipaque 140 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in OMNIPAQUE 140 is iohexol. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iohexol profile page.

Pharmacology for OMNIPAQUE 140

Medical Subject Heading (MeSH) Categories for OMNIPAQUE 140

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
OMNIPAQUE 140
iohexol
INJECTABLE;INJECTION018956-005Nov 30, 1988RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OMNIPAQUE 140

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare
OMNIPAQUE 140
iohexol
INJECTABLE;INJECTION018956-005Nov 30, 1988► Subscribe► Subscribe
Ge Healthcare
OMNIPAQUE 140
iohexol
INJECTABLE;INJECTION018956-005Nov 30, 1988► Subscribe► Subscribe
Ge Healthcare
OMNIPAQUE 140
iohexol
INJECTABLE;INJECTION018956-005Nov 30, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Citi
Medtronic
Express Scripts
QuintilesIMS
Harvard Business School
Novartis
Cantor Fitzgerald
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot